1 July 2024 - In order to standardise practice, Swissmedic will in future publish both the proposed and approved indications in the Swiss Public Assessment Report.
Swissmedic will assess the validity of companies’ claims of commercially confidential information according to the criteria published in the Guidance document SwissPAR.